Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet. 2003;33(2):177-82. doi:10.1038/ng1071
Tabb DL, Wang X, Carr SA, et al. Reproducibility of Differential Proteomic Technologies in CPTAC Fractionated Xenografts. J Proteome Res. 2016;15(3):691-706. doi:10.1021/acs.jproteome.5b00859
Castel SE, Levy-Moonshine A, Mohammadi P, Banks E, Lappalainen T. Tools and best practices for data processing in allelic expression analysis. Genome Biol. 2015;16:195. doi:10.1186/s13059-015-0762-6
Beroukhim R, Getz G, Nghiemphu L, et al. Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc Natl Acad Sci U S A. 2007;104(50):20007-12. doi:10.1073/pnas.0710052104
Holliday EG, Traylor M, Malik R, et al. Genetic overlap between diagnostic subtypes of ischemic stroke. Stroke. 2015;46(3):615-9. doi:10.1161/STROKEAHA.114.007930
Ziller MJ, Hansen KD, Meissner A, Aryee MJ. Coverage recommendations for methylation analysis by whole-genome bisulfite sequencing. Nat Methods. 2015;12(3):230-2, 1 p following 232. doi:10.1038/nmeth.3152
Talwalkar A, Liptrap J, Newcomb J, et al. SMaSH: a benchmarking toolkit for human genome variant calling. Bioinformatics. 2014;30(19):2787-95. doi:10.1093/bioinformatics/btu345
Liu DJ, Peloso GM, Zhan X, et al. Meta-analysis of gene-level tests for rare variant association. Nat Genet. 2014;46(2):200-4. doi:10.1038/ng.2852
Dichgans M, Malik R, König IR, et al. Shared genetic susceptibility to ischemic stroke and coronary artery disease: a genome-wide analysis of common variants. Stroke. 2014;45(1):24-36. doi:10.1161/STROKEAHA.113.002707
Mani DR, Abbatiello SE, Carr SA. Statistical characterization of multiple-reaction monitoring mass spectrometry (MRM-MS) assays for quantitative proteomics. BMC Bioinformatics. 2012;13 Suppl 16:S9. doi:10.1186/1471-2105-13-S16-S9